Skip to main content
Premium Trial:

Request an Annual Quote

GE Healthcare, PerkinElmer, Molecular Devices, Beckman Coulter

Premium

GE Healthcare Revenue Rises 7 Percent in Q3

GE Healthcare on Oct. 14 reported revenue of $3.6 billion for its third quarter ended Sept. 30, a 7-percent increase over revenue of $3.3 billion in the third quarter last year.

GE said total orders for GE Healthcare's Q3 were up 8 percent year over year. The services part of the unit reported 9-percent growth to $1.4 million, and the equipment part of the unit posted 7-percent growth to roughly $2.3 billion.

The healthcare unit of the conglomerate posted a quarterly profit of $589 million, a 17 percent increase year over year.

Overall, parent company GE posted revenue of $41.9 billion for the quarter, a 9-percent increase over revenue of $38.3 billion in the comparable quarter a year ago. The firm also reported net earnings of $4.7 billion, up 15 percent from $4.1 billion in the third quarter of 2004.

GE pointed out that all six of its business units — Healthcare, Infrastructure, Commercial Finance, Consumer Finance, Industrial, and NBC Universal — delivered double-digit earnings growth.


PerkinElmer, Molecular Devices, Beckman Coulter Schedule Q3 Earnings Release

PerkinElmer will release its third-quarter 2005 results on Tuesday, Oct. 25, following the close of market trading.

The company will hold a conference call and slide presentation via webcast to discuss the results that same evening, at 5:30 PM Eastern time. Gregory Summe, chairman and CEO, and Robert Friel, executive vice president and chief financial officer, will host the call.

Molecular Devices said it will release its third-quarter 2005 results on Thursday, Oct. 27, after the close of market trading.

Senior management will hold a conference call the following day, Friday, Oct. 28, at 11 AM Eastern time to discuss operating results and other business matters.

Beckman Coulter said it will release its third-quarter 2005 results on Wednesday, Nov. 2, 2005, before the start of regular market trading.

Beckman will host a conference call on that same morning, at 8:30 AM Eastern time to discuss the results. The call will be hosted by Scott Garrett, president and CEO, and James Glover, senior vice president and CFO.

The Scan

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.

DNA Biobank Developed for French Kidney Donors, Recipients

The KiT-GENIE biobank described in the European Journal of Human Genetics contains DNA samples, genotyping profiles, immune patterns, and clinical features for thousands of kidney donors or transplant recipients in Nantes, France.

Cardiometabolic Disease May Have Distinct Associations With Microbial Metabolites in Blood, Gut

By analyzing gut microbes in combination with related metabolites in feces and blood, researchers in Nature Communications found distinct cardiometabolic disease relationships at each site.

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.